{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:15:27Z","timestamp":1754111727867,"version":"3.37.3"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["Grants 3347C0-108782\/1 and 33CS30-148417\/1 to the Swiss Hepatitis C Cohort Study"],"award-info":[{"award-number":["Grants 3347C0-108782\/1 and 33CS30-148417\/1 to the Swiss Hepatitis C Cohort Study"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AbbVie, Bristol Myers Squibb, Gilead, Janssen-Cilag, MSD, Novartis, Roche Pharma Switzerland and Roche Diagnostics","award":["Unrestricted grants to the Swiss Hepatitis C Cohort Study"],"award-info":[{"award-number":["Unrestricted grants to the Swiss Hepatitis C Cohort Study"]}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["Professorship Grant Number 163878"],"award-info":[{"award-number":["Professorship Grant Number 163878"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0218706","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T13:03:42Z","timestamp":1561467822000},"page":"e0218706","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study"],"prefix":"10.1371","volume":"14","author":[{"given":"Matteo","family":"Brezzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-4245","authenticated-orcid":true,"given":"Barbara","family":"Bertisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maroussia","family":"Roelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius","family":"Moradpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Terziroli Beretta-Piccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Semmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beat","family":"M\u00fcllhaupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Semela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Swiss Hepatitis C Cohort Study","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"T Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection","volume":"3","author":"MP Manns","year":"2017","journal-title":"Nat Rev Dis Primer"},{"issue":"1 Suppl","key":"ref3","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jhep.2016.07.039","article-title":"Reversion of disease manifestations after HCV eradication","volume":"65","author":"AJ van der Meer","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.21927","article-title":"Predictors of treatment in patients with chronic hepatitis C infection\u2014role of patient versus nonpatient factors","volume":"46","author":"F Kanwal","year":"2007","journal-title":"Hepatol"},{"issue":"4","key":"ref5","first-page":"1065","article-title":"Hepatitis C and migration: a public health challenge","volume":"3","author":"M Carballo","year":"2016","journal-title":"J Fam Med"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ajg.2010.430","article-title":"Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study","volume":"106","author":"JR Kramer","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"ref7","unstructured":"Tasks and goals of the Federal Office of Public Health Switzerland\u2014\u201cTaking health to heart\u201d [cited 2019 Feb 8]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.bag.admin.ch\/bag\/en\/home\/das-bag\/auftrag-ziele.html\" xlink:type=\"simple\">https:\/\/www.bag.admin.ch\/bag\/en\/home\/das-bag\/auftrag-ziele.html<\/ext-link>."},{"key":"ref8","unstructured":"Cominetti F, Simonson T, Dubois-Arber F, Gervasoni JP, Schaub M, Monnat M. Analyse de la situation de l`h\u00e9patite C chez les usagers de drogue en Suisse. Sur mandat de l`Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP). February 2015."},{"key":"ref9","unstructured":"Zahnd C, Brezzi M, Bertisch B, Giudici F, Keiser O. Analyse de situation des h\u00e9patites B et C en Suisse, sur mandat de l`Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP). March 23, 2017."},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"B Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2006.07.003","article-title":"Transmission of hepatitis C virus by blood transfusions and other medical procedures: A global review","volume":"45","author":"D Prati","year":"2006","journal-title":"J Hepatol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(96)80020-1","article-title":"Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy","volume":"24","author":"M Chiaramonte","year":"1996","journal-title":"J Hepatol"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/hep.510260431","article-title":"Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy","volume":"26","author":"V Guadagnino","year":"1997","journal-title":"Hepatol"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00042737-200105000-00003","article-title":"Prevalence of hepatitis C virus infection in the general population of northern Spain","volume":"13","author":"S Riestra","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"e0155464","DOI":"10.1371\/journal.pone.0155464","article-title":"Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations","volume":"11","author":"B Bertisch","year":"2016","journal-title":"PLOS ONE"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/jvh.12535","article-title":"Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach","volume":"23","author":"F Giudici","year":"2016","journal-title":"J Viral Hepat"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ije\/dym096","article-title":"Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS)","volume":"36","author":"L Prasad","year":"2007","journal-title":"Int J Epidemiol"},{"key":"ref18","unstructured":"United Nations Statistics Division on the United Nations geographical region classification [cited 2019 Feb 8]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/unstats.un.org\/unsd\/methods\/m49\/m49.htm\" xlink:type=\"simple\">http:\/\/unstats.un.org\/unsd\/methods\/m49\/m49.htm<\/ext-link>."},{"key":"ref19","unstructured":"Swiss Conference of Cantonal Ministers of Education: the Swiss education system [cited 2019 Feb 8]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.edk.ch\/dyn\/16342.php\" xlink:type=\"simple\">http:\/\/www.edk.ch\/dyn\/16342.php<\/ext-link>."},{"issue":"3","key":"ref20","first-page":"1","article-title":"MICE: multivariate imputation by chained equations in R","volume":"45","author":"S Van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"J Sterne","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"ref22","first-page":"259","article-title":"Qualit\u00e4t der Hepatitis-C-Abkl\u00e4rung bei Patienten in Opioid-Substitutionstherapie im Kanton Z\u00fcrich","volume":"17","author":"N Brunner","year":"2015","journal-title":"Suchtmedizin"},{"key":"ref23","first-page":"w13193","article-title":"Management of hepatitis C virus (HCV) infection in drug substitution programs","volume":"141","author":"A Witteck","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"ref24","first-page":"w14544","article-title":"Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade","volume":"147","author":"A Bregenzer","year":"2017","journal-title":"Swiss Med Wkly"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ajg.2015.31","article-title":"Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C Follow-up Study","volume":"110","author":"I Ditah","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41395-018-0033-8","article-title":"Race\/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment","volume":"113","author":"R Wong","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.dld.2014.09.023","article-title":"Epidemiology of hepatitis C in Europe","volume":"46","author":"F Negro","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jhep.2013.11.014","article-title":"The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010","volume":"60","author":"I Ditah","year":"2014","journal-title":"J Hepatol."},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S0618-8278(19)30641-3","article-title":"HCV infection in Canadian immigrants: Characteristics and treatment outcomes of the CANUHC cohort","volume":"70","author":"C Cooper","year":"2019","journal-title":"Journal of Hepatology"},{"key":"ref30","unstructured":"State secretariat for migration, migration report 2014 [cited 2019 Feb 8]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.sem.admin.ch\/dam\/data\/sem\/publiservice\/berichte\/migration\/migrationsbericht-2014-e.pdf\" xlink:type=\"simple\">https:\/\/www.sem.admin.ch\/dam\/data\/sem\/publiservice\/berichte\/migration\/migrationsbericht-2014-e.pdf<\/ext-link>."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2147\/PPA.S49113","article-title":"Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review","volume":"7","author":"V Mrav\u010d\u00edk","year":"2013","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/600304","article-title":"Hepatitis C treatment for injection drug users: a review of the available evidence","volume":"49","author":"M Hellard","year":"2009","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2011.05.021","article-title":"A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse","volume":"56","author":"C Le Lan","year":"2012","journal-title":"J Hepatol"},{"key":"ref34","unstructured":"Negro F. Presentation of the Policy Statements on Hepatitis C Elimination and Migrant Health. At: Public health symposium \u201cLiver disease and the community: Part 2: Hepatitis elimination\u201d. April 14, 2019; International Liver Congress, Vienna. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/easl.meta-dcr.com\/ilc2019\/crs\/presentation-of-the-policy-statements-on-hepatitis-c-elimination-and-migrant-health\" xlink:type=\"simple\">https:\/\/easl.meta-dcr.com\/ilc2019\/crs\/presentation-of-the-policy-statements-on-hepatitis-c-elimination-and-migrant-health<\/ext-link>."},{"key":"ref35","unstructured":"European Centre for Disease Prevention and Control. Epidemiological assessment of hepatitis B and C among migrants in the EU\/EEA. Stockholm: ECDC; 2016."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0218706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:21:15Z","timestamp":1588965675000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0218706"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0218706","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,6,24]]}}}